# Safety and Efficacy of AIN457 in Noninfectious Uveitis

> **NCT00685399** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 76 (actual)

## Conditions studied

- Non-infectious Uveitis

## Interventions

- **DRUG:** AIN457
- **DRUG:** AIN 457
- **DRUG:** AIN457

## Key facts

- **NCT ID:** NCT00685399
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2017-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00685399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00685399, "Safety and Efficacy of AIN457 in Noninfectious Uveitis". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00685399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*